{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:56:32Z","timestamp":1794750992287,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We present a process for solid phase peptide synthesis (SPPS) that completely eliminates all solvent intensive washing steps during each amino acid addition cycle. A key breakthrough is the removal of a volatile Fmoc deprotection base through bulk evaporation at elevated temperature while preventing condensation on the vessel surfaces with a directed headspace gas flushing. This process was demonstrated at both research and production scales without any impact on product quality and when applied to a variety of challenging sequences (up to 89 amino acids in length). The overall result is an extremely fast, high purity, scalable process with a massive waste reduction (up to 95%) while only requiring 10\u201315% of the standard amount of base used. This transformation of SPPS represents a step-change in peptide manufacturing process efficiency, and should encourage expanded access to peptide-based therapeutics.<\/jats:p>","DOI":"10.1038\/s41467-023-44074-5","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T09:02:31Z","timestamp":1702112551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Total wash elimination for solid phase peptide synthesis"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5918-8677","authenticated-orcid":false,"given":"Jonathan M.","family":"Collins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5061-3174","authenticated-orcid":false,"given":"Sandeep K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-257X","authenticated-orcid":false,"given":"Drew J.","family":"Cesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0710-9879","authenticated-orcid":false,"given":"Colin L.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6279-4696","authenticated-orcid":false,"given":"Levi J.","family":"Tubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Houser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,9]]},"reference":[{"key":"44074_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","volume":"20","author":"M Muttenthaler","year":"2021","unstructured":"Muttenthaler, M., King, G. F., Adams, D. J. & Alewood, P. F. Trends in peptide drug discovery. Nat. Rev. Drug Discov. 20, 309\u2013325 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"44074_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Therapeutic peptides: current applications and future directions. Sig Transduct. Target Ther. 7, 48 (2022).","journal-title":"Sig Transduct. Target Ther."},{"key":"44074_CR3","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.3390\/cells10112908","volume":"10","author":"CM Li","year":"2021","unstructured":"Li, C. M. et al. Novel peptide therapeutic approaches for cancer treatment. Cells 10, 2908 (2021).","journal-title":"Cells"},{"key":"44074_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s12276-023-01016-x","volume":"55","author":"SMP Vadevoo","year":"2023","unstructured":"Vadevoo, S. M. P. et al. Peptides as multifunctional players in cancer therapy. Exp. Mol. Med. 55, 1099\u20131109 (2023).","journal-title":"Exp. Mol. Med."},{"key":"44074_CR5","doi-asserted-by":"publisher","first-page":"8642","DOI":"10.3390\/ijms24108642","volume":"24","author":"S Li","year":"2023","unstructured":"Li, S. et al. Therapeutic peptides for treatment of lung diseases: infection, fibrosis, and cancer. Int. J. Mol. Sci. 24, 8642 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"44074_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","volume":"14","author":"A Andersen","year":"2018","unstructured":"Andersen, A., Lund, A., Knop, F. K. & Vilsb\u00f8ll, T. Glucagon-like peptide 1 in health and disease. Nat. Rev. Endocrinol. 14, 390\u2013403 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"44074_CR7","unstructured":"US Food and Drug Administration. FDA approves new drug treatment for chronic weight management, first since 2014. [Press release]. 2021. www.fda.gov\/news-events\/press-announcements\/fda-approves-new-drug-treatment-chronic-weight-management-first-2014 Available at: (accessed 26 June 2023)."},{"key":"44074_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1039\/9781788016445-00111","volume":"72","author":"S Kota","year":"2019","unstructured":"Kota, S. Peptide manufacturing methods and challenges. Pept. therapeutics: strategy tactics Chem., Manuf., controls 72, 111\u2013150 (2019).","journal-title":"Pept. therapeutics: strategy tactics Chem., Manuf., controls"},{"key":"44074_CR9","unstructured":"US Food and Drug Administration. ANDAs for certain highly purified synthetic peptide drug products that refer to listed drugs of rDNA origin: Guidance for industry. https:\/\/www.fda.gov\/regulatory-information."},{"key":"44074_CR10","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1021\/ja00897a025","volume":"85","author":"RB Merrifield","year":"1963","unstructured":"Merrifield, R. B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85, 2149\u20132154 (1963).","journal-title":"J. Am. Chem. Soc."},{"key":"44074_CR11","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1021\/ja00722a043","volume":"92","author":"LA Carpino","year":"1970","unstructured":"Carpino, L. A. & Han, G. Y. 9-Fluorenylmethoxycarbonyl function, a new base-sensitive amino-protecting group. J. Am. Chem. Soc. 92, 5748\u20135749 (1970).","journal-title":"J. Am. Chem. Soc."},{"key":"44074_CR12","doi-asserted-by":"crossref","unstructured":"Rapp, W. PEG Grafted Polystyrene Tentacle Polymers: Physicochemical Properties and Application in Chemical Synthesis. 425-464 (VCH, Weinheim, 1996).","DOI":"10.1002\/9783527614912.ch16"},{"key":"44074_CR13","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1055\/s-0040-1706296","volume":"52","author":"SR Manne","year":"2020","unstructured":"Manne, S. R., de la Torre, B. G., El-Faham, A. & Albericio, F. OxymaPure coupling reagents: beyond solid-phase peptide synthesis. Synthesis 52, 3189\u20133210 (2020).","journal-title":"Synthesis"},{"key":"44074_CR14","doi-asserted-by":"crossref","unstructured":"Chan, W. C. & White, P. D. Fmoc Solid Phase Peptide Synthesis: A Practical Approach (Oxford University Press, New York, 2000).","DOI":"10.1093\/oso\/9780199637256.001.0001"},{"key":"44074_CR15","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1021\/acs.joc.8b03001","volume":"84","author":"A Isidro-Llobet","year":"2019","unstructured":"Isidro-Llobet, A. et al. Sustainability challenges in peptide synthesis and purification: from R&D to production. J. Org. Chem. 84, 4615\u20134628 (2019).","journal-title":"J. Org. Chem."},{"key":"44074_CR16","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1021\/jo00044a001","volume":"57","author":"HM Yu","year":"1992","unstructured":"Yu, H. M., Chen, S. T. & Wang, K. T. Enhanced coupling efficiency in solid-phase peptide synthesis by microwave irradiation. J. Org. Chem. 57, 4781\u20134784 (1992).","journal-title":"J. Org. Chem."},{"key":"44074_CR17","doi-asserted-by":"crossref","unstructured":"Mate, E. & Gogoll, A. Rapid microwave-assisted solid phase peptide synthesis. Synthesis 1592\u20131596 (2002).","DOI":"10.1055\/s-2002-33348"},{"key":"44074_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/psc.804","volume":"13","author":"SA Palasek","year":"2007","unstructured":"Palasek, S. A., Cox, Z. J. & Collins, J. M. Limiting racemization and aspartimide formation in microwave\u2010enhanced Fmoc solid phase peptide synthesis. J. Pept. Sci. 13, 143\u2013148 (2007).","journal-title":"J. Pept. Sci."},{"key":"44074_CR19","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1021\/ol4036825","volume":"16","author":"JM Collins","year":"2014","unstructured":"Collins, J. M., Porter, K. A., Singh, S. K. & Vanier, G. S. High-efficiency solid phase peptide synthesis (HE-SPPS). Org. Lett. 16, 940\u2013943 (2014).","journal-title":"Org. Lett."},{"key":"44074_CR20","unstructured":"Collins, J. M. In-situ solvent recycling process for solid phase peptide synthesis at elevated temperatures. U.S. Patent 10239914B2, 2019\/03\/26, (2019)."},{"key":"44074_CR21","doi-asserted-by":"crossref","unstructured":"Singh, S. K. & Collins, J. M. New developments in microwave-assisted solid phase peptide synthesis. In Peptide Synthesis: Methods and Protocols, Hussein, W. M.; Skwarczynski, M.; Toth, I., Eds. 95-109 (Springer, New York, 2020).","DOI":"10.1007\/978-1-0716-0227-0_6"},{"key":"44074_CR22","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1039\/D2GC00963C","volume":"24","author":"A Kumar","year":"2022","unstructured":"Kumar, A., Sharma, A., de la Torre, B. G. & Albericio, F. In situ Fmoc removal-a sustainable solid-phase peptide synthesis approach. Green. Chem. 24, 4887\u20134896 (2022).","journal-title":"Green. Chem."},{"key":"44074_CR23","unstructured":"Brown, R. L. & Stein, S. E. Boiling Point Data. In NIST Chemistry WebBook, NIST Standard Reference Database U.S. Department of Commerce: National Institute of Standards and Technology, Gaithersburg MD, Vol. 69."},{"key":"44074_CR24","doi-asserted-by":"publisher","first-page":"14202","DOI":"10.1021\/acssuschemeng.1c04770","volume":"9","author":"PHG Egelund","year":"2021","unstructured":"Egelund, P. H. G. et al. Fmoc-removal with pyrrolidine expands the available solvent space in green solid-phase peptide synthesis. ACS Sustain. Chem. Eng. 9, 14202\u201314215 (2021).","journal-title":"ACS Sustain. Chem. Eng."},{"key":"44074_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.7150\/ijms.5374","volume":"10","author":"R Pipkorn","year":"2013","unstructured":"Pipkorn, R. et al. SPPS resins impact the PNA-syntheses\u2019 improvement. Int. J. Med. Sci. 10, 331\u2013337 (2013).","journal-title":"Int. J. Med. Sci."},{"key":"44074_CR26","unstructured":"US Patent Application 63\/401,349"},{"key":"44074_CR27","doi-asserted-by":"publisher","first-page":"7519","DOI":"10.1016\/j.tetlet.2004.07.162","volume":"45","author":"LA Carpino","year":"2004","unstructured":"Carpino, L. A. et al. Synthesis of \u2018difficult\u2019 peptide sequences: application of a depsipeptide technique to the Jung-Redemann 10- and 26-mers and the amyloid peptide A\u03b2(1\u201342). Tetrahedron Lett. 45, 7519\u20137523 (2004).","journal-title":"Tetrahedron Lett."},{"key":"44074_CR28","unstructured":"Redemann, T. & Jung, G. Peptides 1996 - Proceedings of the 24th European Peptide Symposium 749\u2013750 (1996)."},{"key":"44074_CR29","doi-asserted-by":"publisher","first-page":"14598","DOI":"10.1039\/C9CC08421E","volume":"55","author":"ET Sletten","year":"2019","unstructured":"Sletten, E. T., Nu\u00f1o, M., Guthrie, D. & Seeberger, P. H. Real-time monitoring of solid-phase peptide synthesis using a variable bed flow reactor. Chem. Commun. 55, 14598\u201314601 (2019).","journal-title":"Chem. Commun."},{"key":"44074_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nchembio.2318","volume":"13","author":"AJ Mijalis","year":"2017","unstructured":"Mijalis, A. J. et al. A fully automated flow-based approach for accelerated peptide synthesis. Nat. Chem. Biol. 13, 464\u2013466 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"44074_CR31","doi-asserted-by":"publisher","first-page":"154301","DOI":"10.1016\/j.tetlet.2022.154301","volume":"115","author":"S Manne","year":"2023","unstructured":"Manne, S., Rustler, K., Bruckdorfer, T., de la Torre, B. G. & Albericio, F. Incorporation of pseudoproline monomer (Fmoc-Thr[\u03c8Me,Mepro]-OH) facilitates efficient solid-phase synthesis of difficult peptides. Tetrahedron Lett. 115, 154301 (2023).","journal-title":"Tetrahedron Lett."},{"key":"44074_CR32","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1246\/bcsj.46.2219","volume":"46","author":"M Itoh","year":"1973","unstructured":"Itoh, M. Peptides. IV. Racemization suppression by the Use of ethyl 2-hydroximino-2-cyanoacetate and its amide. Bull. Chem. Soc. Jpn. 46, 2219\u20132221 (1973).","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"44074_CR33","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1021\/acs.oprd.9b00344","volume":"23","author":"AD McFarland","year":"2019","unstructured":"McFarland, A. D., Buser, J. Y., Embry, M. C., Held, C. B. & Kolis, S. P. Generation of hydrogen cyanide from the reaction of Oxyma (ethyl cyano(hydroxyimino)acetate) and DIC (diisopropylcarbodiimide). Org. Process Res. Dev. 23, 2099\u20132105 (2019).","journal-title":"Org. Process Res. Dev."},{"key":"44074_CR34","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1021\/acs.oprd.7b00389","volume":"22","author":"J Lopez","year":"2018","unstructured":"Lopez, J., Pletscher, S., Aemissegger, A., Bucher, C. & Gallou, F. N-butylpyrrolidinone as alternative solvent for solid-phase peptide synthesis. Org. Process Res. Dev. 22, 494\u2013503 (2018).","journal-title":"Org. Process Res. Dev."},{"key":"44074_CR35","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1002\/cssc.202101028","volume":"14","author":"J Pawlas","year":"2021","unstructured":"Pawlas, J. & Rasmussen, J. H. Circular aqueous fmoc\/t\u2010bu solid\u2010phase peptide synthesis. ChemSusChem 14, 3231\u20133236 (2021).","journal-title":"ChemSusChem"},{"key":"44074_CR36","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1039\/D1GC00603G","volume":"23","author":"V Martin","year":"2021","unstructured":"Martin, V. et al. Harnessing polarity and viscosity to identify green binary solvent mixtures as viable alternatives to DMF in solid-phase peptide synthesis. Green. Chem. 23, 3295\u20133311 (2021).","journal-title":"Green. Chem."},{"key":"44074_CR37","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1039\/D1GC00910A","volume":"23","author":"G Martelli","year":"2021","unstructured":"Martelli, G. et al. Steps towards sustainable solid phase peptide synthesis: use and recovery of N-octyl pyrrolidone. Green. Chem. 23, 4095\u20134106 (2021).","journal-title":"Green. Chem."},{"key":"44074_CR38","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1021\/acs.oprd.1c00021","volume":"25","author":"I Guryanov","year":"2021","unstructured":"Guryanov, I. et al. Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists liraglutide and semaglutide. Org. Process Res. Dev. 25, 1598\u20131611 (2021).","journal-title":"Org. Process Res. Dev."},{"key":"44074_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1021\/acscombsci.0c00134","volume":"22","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Total synthesis of semaglutide based on a soluble hydrophobic-support-assisted liquid-phase synthetic method. ACS Comb. Sci. 22, 821\u2013825 (2020).","journal-title":"ACS Comb. Sci."},{"key":"44074_CR40","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/psc.342","volume":"7","author":"AK Tickler","year":"2001","unstructured":"Tickler, A. K., Barrow, C. J. & Wade, J. D. Improved preparation of amyloid-\u03b2 peptides using DBU as N\u03b1-Fmoc deprotection reagent. J. Pept. Sci. 7, 488\u2013494 (2001).","journal-title":"J. Pept. Sci."},{"key":"44074_CR41","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fchem.2019.00472","volume":"7","author":"JK Kasim","year":"2019","unstructured":"Kasim, J. K., Kavianinia, I., Harris, P. W. R. & Brimble, M. A. Three decades of amyloid beta synthesis: challenges and advances. Front. Chem. 7, 472 (2019).","journal-title":"Front. Chem."},{"key":"44074_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1039\/C8OB02929F","volume":"17","author":"JK Kasim","year":"2019","unstructured":"Kasim, J. K. et al. Efficient synthesis and characterisation of the amyloid beta peptide, A\u03b21\u201342, using a double linker system. Org. Biomol. Chem. 17, 30\u201334 (2019).","journal-title":"Org. Biomol. Chem."},{"key":"44074_CR43","unstructured":"Gerhardt, J. & Nicholson, G. J. Validation of a GC-MS method for determination of the optical purity of peptides. GmbH, C. A. T., Ed."},{"key":"44074_CR44","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.abb2491","volume":"368","author":"N Hartrampf","year":"2020","unstructured":"Hartrampf, N. et al. Synthesis of proteins by automated flow chemistry. Science 368, 980\u2013987 (2020).","journal-title":"Science"},{"key":"44074_CR45","unstructured":"Johnson, M. D., Kopach, M. E. & Webster, L. P. Resin reactors in series peptide synthesizer. Patent WO2021158444, 2021\/12\/08, (2021)."},{"key":"44074_CR46","doi-asserted-by":"publisher","first-page":"1000071","DOI":"10.1016\/j.medidd.2020.100071","volume":"9","author":"MW Pennington","year":"2021","unstructured":"Pennington, M. W., Zell, B. & Bai, C. J. Commerical manufacturing of current good manufacturing practice peptides spanning the gamut from neoantigen to commercial large-scale products. Med. Drug Discov. 9, 1000071 (2021).","journal-title":"Med. Drug Discov."},{"key":"44074_CR47","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1039\/C8GC01276H","volume":"20","author":"MC Bryan","year":"2018","unstructured":"Bryan, M. C. et al. Key green chemistry research areas from a pharmaceutical manufacturers\u2019 perspective revisited. Green. Chem. 20, 5082\u20135103 (2018).","journal-title":"Green. Chem."},{"key":"44074_CR48","unstructured":"Regulation (EU) No 2021\/2030. http:\/\/data.europa.eu\/eli\/reg\/2021\/2030\/oj; Accessed June 29, 2023."},{"key":"44074_CR49","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1021\/acs.analchem.5b00140","volume":"87","author":"MT Marty","year":"2015","unstructured":"Marty, M. T. et al. Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles. Anal. Chem. 87, 4370\u20134376 (2015).","journal-title":"Anal. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44074-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44074-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T09:03:43Z","timestamp":1702112623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44074-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["44074"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-44074-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,9]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: All authors work at CEM Corporation which develops and manufactures the peptide synthesizers used in this study. J.M.C. and S.K.S. are co-inventors on a U.S. provisional patent application with application serial number 63\/401,349 filed by CEM Corporation. The invention covers the aspects of headspace gas flushing for wash-free solid-phase peptide synthesis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8168"}}